NCT04349839View on ClinicalTrials.gov

ACRODAT Prospective Evaluation Study

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

October 1, 2023

Study Completion Date

February 1, 2025

Conditions
Acromegaly
Interventions
DEVICE

Acrodat software

Acrodat is a newly developed software medical device to access disease activity in acromegaly based on five parameters: IGF-I, tumour size, comorbidities, symptoms and quality of life.

Trial Locations (1)

8200

Århus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER